These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2653923)

  • 1. Nootropics and metabolically active compounds in Alzheimer's disease.
    Nicholson CD
    Biochem Soc Trans; 1989 Feb; 17(1):83-5. PubMed ID: 2653923
    [No Abstract]   [Full Text] [Related]  

  • 2. Glial modulating and neurotrophic properties of propentofylline and its application to Alzheimer's disease and vascular dementia.
    Ringheim GE
    Ann N Y Acad Sci; 2000 Apr; 903():529-34. PubMed ID: 10818548
    [No Abstract]   [Full Text] [Related]  

  • 3. Nootropics: preclinical results in the light of clinical effects; comparison with tacrine.
    Mondadori C
    Crit Rev Neurobiol; 1996; 10(3-4):357-70. PubMed ID: 8978986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nootropic drugs and aging.
    Giurgea CE; Greindl MG; Preat S
    Acta Psychiatr Belg; 1983; 83(4):349-58. PubMed ID: 6660010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piracetam combined with lecithin in the treatment of Alzheimer's disease.
    Growdon JH; Corkin S; Huff FJ; Rosen TJ
    Neurobiol Aging; 1986; 7(4):269-76. PubMed ID: 3528889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning and memory in rats exposed pre- and postnatally to alcohol. An attempt at pharmacological control.
    Petkov VD; Konstantinova ER; Petkov VV; Vaglenova JV
    Methods Find Exp Clin Pharmacol; 1991; 13(1):43-50. PubMed ID: 1870356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study of the nootropic properties of piracetam and oxiracetam].
    Krylova IN; Antonova LV; Kamenskiĭ AA; Iasnetsov VV
    Farmakol Toksikol; 1991; 54(1):14-6. PubMed ID: 1860490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-clinical evaluation of cognition enhancing drugs.
    Schindler U
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S99-115. PubMed ID: 2694232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.
    Nicholson CD
    Psychopharmacology (Berl); 1990; 101(2):147-59. PubMed ID: 2190256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the pattern of neuropsychological improvement obtained with cholinergic drugs be used to infer a cholinergic mechanism in other nootropic drugs?
    Gainotti G; Nocentini U; Sena E
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S47-59. PubMed ID: 2694229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of nootropics on memory: new aspects for basic research.
    Mondadori C; Petschke F; Häusler A
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():102-6. PubMed ID: 2690149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of a steroidal component in the mechanism of action of piracetam-like nootropics.
    Mondadori C; Bhatnagar A; Borkowski J; Häusler A
    Brain Res; 1990 Jan; 506(1):101-8. PubMed ID: 2137359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease. Is it worth treating?
    Hollister LE
    Drugs; 1985 Jun; 29(6):483-8. PubMed ID: 4006773
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacology of the nootropics; new insights and new questions.
    Mondadori C
    Behav Brain Res; 1993 Dec; 59(1-2):1-9. PubMed ID: 8155275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of amiridin and tacrine, drugs effective in Alzheimer's disease, on the activity of monoamine oxidase A and B].
    Burov IuV; Baĭmanov TD; Tat'ianenko LV; Sokolova NM; Tereshchenkova IM
    Biull Eksp Biol Med; 1992 Feb; 113(2):149-50. PubMed ID: 1611059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated corticosteroid levels block the memory-improving effects of nootropics and cholinomimetics.
    Mondadori C; Ducret T; Häusler A
    Psychopharmacology (Berl); 1992; 108(1-2):11-5. PubMed ID: 1410129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the effects on learning and memory of nootropic drugs and central stimulants when applied together.
    Petkov VD; Konstantinova E; Petkov VV; Lazarova M; Petkova B
    Acta Physiol Pharmacol Bulg; 1991; 17(4):17-26. PubMed ID: 1688150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nootropic drugs on the learning- and memory-impairing effect of diethyldithiocarbamate in albino rats.
    Genkova MG; Lazarova MB
    Methods Find Exp Clin Pharmacol; 1988 Jun; 10(6):369-75. PubMed ID: 2842556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease. Drug therapies.
    Cutler NR; Narang PK
    Geriatr Nurs; 1985; 6(3):160-3. PubMed ID: 2859236
    [No Abstract]   [Full Text] [Related]  

  • 20. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
    Cummings JL; Mendez MF
    Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.